Advertisement

Topics

Latest "TwoXAR, Inc." News Stories

02:12 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "TwoXAR, Inc." found in our extensive news archives from over 250 global news sources.

More Information about TwoXAR, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about TwoXAR, Inc. for you to read. Along with our medical data and news we also list TwoXAR, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of TwoXAR, Inc. Companies for you to search.

Showing "TwoXAR" News Articles, all 4

Wednesday 28th November 2018

twoXAR Receives $225K Phase I SBIR Grant for Pancreatic Cancer Drug Discovery

Identifying novel PDAC candidates using a computational approach twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced it has received a $225,030 Phase I Small Business Innovation Research (SBIR) award from the National Cancer Institute of the National Institutes of Health. The one-year award will fund a progra...


Thursday 15th November 2018

Adynxx and twoXAR Form Collaboration to Discover and Develop Treatments for Endometriosis

Drug Development Approach Combines twoXAR’s Artificial Intelligence-Driven Discovery Technology with the Adynxx Team’s Development Experience Adynxx, Inc., a clinical-stage biotechnology company focused on pain and inflammation, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to devel...

Wednesday 17th October 2018

Twoxar Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company that develops novel drug candidates. The company's drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. Its research programs include gene expression, proteininteraction, chemical structure, MOA, and clinical data...


Monday 13th August 2018

Twoxar Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company that develops novel drug candidates. The company's drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. Its research programs include gene expression, proteininteraction, chemical structure, MOA, and clinical data...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks